CBD of Denver Outlines Growth Plan for Greece
The company targets increased production capacity at its facility in Nea Apollonia, Greece.
Updated on Oct. 29, 2026 in Biotech
Live Poll
Do you support the continued expansion and commercial growth of the European cannabinoid market?
CBD of Denver has announced new strategic priorities for its BioCannabis platform aimed at scaling operations in Greece. The company intends to increase production volumes and develop value-added cannabinoid products to capture more market share.
Why it matters
Expanding post-harvest and processing capabilities allows the firm to move beyond basic cultivation to higher-value goods. This shift positions the company to benefit from the projected growth of the European cannabidiol market.
The BioCannabis platform operates 7,200 square meters of total facilities, including 5,000 square meters dedicated to greenhouse cultivation. The site currently maintains an annual dried-flower production capacity of 3,000 kilograms.
The players
CBD of Denver
This is a company focused on the development and operation of cannabis-related platforms.
The details
The firm combines cultivation, processing, and extraction into a single, integrated operation. By optimizing these facilities, the company seeks to improve efficiency while expanding its catalog of value-added cannabinoid offerings.
Timeline
The European cannabidiol market reached a value of USD 2.3 billion in 2025.
CBD of Denver outlined its strategic priorities on October 29, 2026.
The European cannabidiol market is projected to grow to approximately USD 6.0 billion by 2033.
The Tech Race
The firm’s focus on value-added cannabinoids mirrors the industry shift toward specialized production to compete in an evolving European market. It reflects a transition from volume-based raw commodity production to complex, high-margin extraction processes.
Increased local production capacity may eventually lead to greater availability of processed cannabinoid goods for regional consumers. It also represents a potential shift in supply chains as the firm moves to capture more value internally.
The takeaway
Companies in the cannabis sector are increasingly prioritizing integrated processing to move up the value chain. Investors and stakeholders should watch for how successfully these firms balance cultivation volume with high-value extraction output.
Further reading
Learn more about local industry developments in the Biotech section.
Source note: This article includes information reported by Simcoe Reformer.
Live Poll
Do you support the continued expansion and commercial growth of the European cannabinoid market?
